The WEHI Parkinson’s Disease Research Centre has made a groundbreaking discovery by uncovering the structure of the human PINK1 protein. This crucial protein, linked to Parkinson’s disease, had remained elusive for over 20 years. The findings, published in Science, mark a major milestone in the quest to understand and treat Parkinson’s disease.
Significance of the Discovery
Understanding the structure and activation of PINK1 is revolutionary for several reasons:
- Potential for New Treatments: With the structure of PINK1 now revealed, scientists can develop targeted therapies that activate this protein, potentially slowing or stopping the progression of Parkinson’s disease.
- Insight into Disease Mechanisms: The discovery offers a detailed understanding of how PINK1 interacts with mitochondria and how mutations lead to the accumulation of damaged mitochondria, a hallmark of Parkinson’s.
- Hope for Patients: This breakthrough provides renewed hope to the over 200,000 Australians living with Parkinson’s, particularly those with Young Onset Parkinson’s Disease.
Breakthrough: What role PINK1 Protein plays
PINK1 plays a pivotal role in maintaining cellular health by marking damaged mitochondria for removal. In patients with Parkinson’s, mutations in PINK1 disrupt this process, leading to cell death. By visualizing PINK1 for the first time, researchers have unlocked potential new avenues for drug development.
Empowering Women in Science
This discovery highlights the critical contributions of women in scientific research. Dr Sylvie Callegari and Dr Alisa Glukhova, leading researchers at WEHI, played a key role in this study. The work of the team which includes Professor David Komander and Dr Nicholas Kirk, exemplifies the innovation and dedication driving advances in medical science, making a difference in the lives of countless individuals.
You can support WEHI here